AbbVie
ABBV
ABBV
3,127 hedge funds and large institutions have $196B invested in AbbVie in 2023 Q1 according to their latest regulatory filings, with 158 funds opening new positions, 1,244 increasing their positions, 1,356 reducing their positions, and 117 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
less ownership
Funds ownership: →
less funds holding
Funds holding: →
8% less repeat investments, than reductions
Existing positions increased: 1,244 | Existing positions reduced: 1,356
13% less funds holding in top 10
Funds holding in top 10: 346 → 301 (-45)
23% less capital invested
Capital invested by funds: $255B → $196B (-$58.3B)
Holders
3,127
Holding in Top 10
301
Calls
$3.15B
Puts
$2.04B
Top Buyers
| 1 | +$1.99B | |
| 2 | +$688M | |
| 3 | +$401M | |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$342M |
| 5 |
Citadel Advisors
Miami,
Florida
|
+$285M |
Top Sellers
| 1 | -$1.71B | |
| 2 | -$693M | |
| 3 | -$480M | |
| 4 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$454M |
| 5 |
Franklin Resources
San Mateo,
California
|
-$436M |